Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lupin eyes $300 mn revenues from Japan in next 2 yrs
Zee News, India
Sunday, December 11, 2011 - 2:51pm
tags:
Lupin
Pharmacyclics' Sale Of Blood Cancer Drug To J&J Is A Big Deal
Seeking Alpha
Sunday, December 11, 2011 - 2:49pm
tags:
Pharmacyclics, JNJ, PCI-32765
How Does Johnson & Johnson Boost its Returns?
Motley Fool
Sunday, December 11, 2011 - 2:48pm
tags:
JNJ
Amgen More Undervalued Than Johnson & Johnson
Seeking Alpha
Sunday, December 11, 2011 - 2:45pm
tags:
Amgen, JNJ
Spectrum's Fusilev Sales Will Suffer As Leucovorin Shortage Is Eliminated
Seeking Alpha
Sunday, December 11, 2011 - 2:44pm
tags:
Spectrum Pharmaceuticals, Fusilev, leucovorin, colon cancer
Micromet’s Blinatumomab Produces Durable Responses in Patients with Relapsed Diffuse Large B Cell Lymphoma Patients
Yahoo/BusinessWire
Sunday, December 11, 2011 - 2:42pm
tags:
Micromet, blinatumomab, lymphoma
20 Biotech Stocks That Hedge Funds Are Selling
Seeking Alpha
Sunday, December 11, 2011 - 2:40pm
tags:
Nabi, Pacific Biosciences, Dendreon, Momenta, Enzon, Acorda Therapeutics, ShangPharma, Charles River Laboratories, Sangamo BioSciences, BioSpecifics Technologies, Jazz Pharmaceuticals, Amgen, Sinovac Biotech, ViroPharma, Vanda, Insmed, Transcept, Cadence Pharmaceuticals, PDL Biopharma, Chelsea Therapeutics
US FDA panel gives positive opinion to Affymax's anaemia drug peginesatide
Pharmabiz
Saturday, December 10, 2011 - 1:23pm
tags:
Affymax, peginesatide, Takeda, chronic kidney disease
US FDA approves Antares' oxybutynin gel for overactive bladder treatment
Pharmabiz
Saturday, December 10, 2011 - 1:21pm
tags:
Antares Pharma, oxybutynin gel, overactive bladder
Big pharma appears to be responding to treatment
Financial Times, UK
Saturday, December 10, 2011 - 1:09pm
tags:
Hot Stock: Alexza Pharmaceuticals, Shares Gain 9.6% (ALXA)
Financial News Network
Saturday, December 10, 2011 - 1:05pm
tags:
Alexza
Sun Pharma gets USFDA approval for generic Ultram ER tablets‎
NDTV
Saturday, December 10, 2011 - 1:04pm
tags:
Sun Pharma, Ultram ER, generics
TaiGen Biotechnology Obtains the Worldwide Rights for Nemonoxacin
Sacramento Bee, Ca
Saturday, December 10, 2011 - 1:02pm
tags:
TaiGen, Nemonoxacin, antibiotics
BioChemics Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Osteoarthritis Read more: BioChemics Announces Positive Phase 2 Data for a Novel Transdermal Ibuprofen Drug Formulation Developed to Treat Os
FierceBiotech
Saturday, December 10, 2011 - 1:01pm
tags:
BioChemics Inc, VALE, osteoarthritis
Bristol-Myers Presents Data
Yahoo/Zacks
Saturday, December 10, 2011 - 12:56pm
tags:
Bristol-Myers Squibb, AstraZeneca, diabetes, Dapagliflozin, glimepiride, Merck, NovoNordisk
FDA panel backs benefit of birth control patch
Yahoo/AP
Saturday, December 10, 2011 - 12:53pm
tags:
birth control, contraceptives, Ortho Evra, JNJ, birth control patch, contraceptive patch
J&J in Oncology Deal
Yahoo/Zacks
Saturday, December 10, 2011 - 12:52pm
tags:
JNJ, Pharmacyclics, PCI-32765, hematologic cancers, leukemia, lymphoma
Pfizer Faces Hazy Future Beyond Lipitor
The Street
Saturday, December 10, 2011 - 12:50pm
tags:
Pfizer, Lipitor
Apixaban- Pfizer's Multi-Billion Dollar Income Replacement For Lipitor
Seeking Alpha
Saturday, December 10, 2011 - 12:48pm
tags:
Apixaban, Pfizer, anticoagulants
Pharmacyclics Shares Plunged: What You Need to Know
Motley Fool
Saturday, December 10, 2011 - 12:47pm
tags:
Pharmacyclics, JNJ

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.